Latest News in Cancer
Stay updated with the most recent articles and resources.
Main Topics
Bosutinib is approved by the FDA for pediatric patients with chronic myelogenous leukemia
The Food and Drug Administration approved bosutinib (Bosulif, Pfizer) for pediatric patients 1 year of age and older with chronic phase (CP) Ph+ chronic myelogenous...
New and updated indications are approved by FDA for temozolomide under Project Renewal
The Food and Drug Administration (FDA) approved updated labeling for temozolomide (Temodar, Merck) under Project Renewal, an Oncology Center of Excellence (OCE) initiative aimed at...
Melphalan is approved by FDA as a liver-directed treatment for uveal melanoma
HEPZATO KIT (melphalan for Injection/Hepatic Delivery System, Delcath Systems, Inc.) was approved by the Food and Drug Administration as a liver-directed treatment for adult patients...
Elranatamab-bcmm receives accelerated approval by FDA for multiple myeloma
Elranatamab-bcmm (Elrexfio, Pfizer, Inc.) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager that was given accelerated approval by the Food and Drug Administration...
CAR T Cell Therapy: How Does It Work?
Discover the science behind CAR T Cell therapy treatment in India! Explore how this revolutionary treatment transforms your immune cells into cancer fighters. Read our...
Is CAR T-Cell Therapy Available In India?
Have you ever wondered if there is a powerful way to fight cancer? Now just imagine if one day you found a ray of hope...
Niraparib and abiraterone acetate plus prednisone is approved by FDA for BRCA-mutated metastatic castration-resistant prostate cancer
The Food and Drug Administration approved the fixed dose combination of niraparib and abiraterone acetate (Akeega, Janssen Biotech, Inc.), with prednisone, for adult patients with...
Talquetamab-tgvs has received accelerated approval for relapsed or refractory multiple myeloma
The Food and Drug Administration granted accelerated approval to talquetamab-tgvs (Talvey, Janssen Biotech, Inc.) for adults with relapsed or refractory multiple myeloma who have received...
Pralsetinib is approved by the FDA for non-small cell lung cancer with RET gene fusions
August 2023: Pralsetinib (Gavreto, Genentech, Inc.) was given regular approval by the Food and Drug Administration for adult patients with metastatic RET fusion-positive non-small cell lung...
Trifluridine and tipiracil with bevacizumab is approved by FDA for previously treated metastatic colorectal cancer
The Food and Drug Administration approved trifluridine and tipiracil (LONSURF, Taiho Oncology, Inc.) with bevacizumab, for metastatic colorectal cancer (mCRC) previously treated with fluoropyrimidine-, oxaliplatin-...
Dostarlimab-gxly with chemotherapy is approved by the FDA for endometrial cancer
The Food and Drug Administration approved dostarlimab-gxly (Jemperli, GlaxoSmithKline) with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for primary advanced or recurrent endometrial cancer (EC)...
Quizartinib is approved by the FDA for newly diagnosed acute myeloid leukemia
The Food and Drug Administration approved quizartinib (Vanflyta, Daiichi Sankyo, Inc.) with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance monotherapy following...
Need help? Our team is ready to assist you.
We wish a speedy recovery for your loved ones.